Missed opportunities to prevent <scp>HIV</scp> acquisition with pre‐exposure prophylaxis: A mixed methods study of people with recently acquired <scp>HIV</scp> in the <scp>United Kingdom</scp>

PrEP barriers vary by population. For GBMSM, addressing barriers to uptake/adherence (e.g., EBD challenges) are key, highlighting the potential benefit of long-acting injectables. However, awareness of PrEP remains a key challenge for women to achieve equity in prevention.